Ali Asif, CFO of Protagonist Therapeutics ($PTGX), sold about $4.6 million worth of company shares in four open market transactions over the last year. His most recent sale occurred on January 27, 2026. These sales rank 2048th among 11,678 insiders in the database by total value sold, below the average of $8.6 million across about 6 transactions per insider. Asif made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 26, 2026 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | M | Common Stock | 19500 | $19.19 | 80,253.0000 | 63,573,048 | 32.10% | 0.03% |
| March 26, 2026 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | M | Stock Option (right to buy) | 5265 | $0.00 | 13,282.0000 | 63,573,048 | 28.39% | 0.01% |
| March 26, 2026 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | M | Stock Option (right to buy) | 19500 | $0.00 | 31,300.0000 | 63,573,048 | 38.39% | 0.03% |
| March 26, 2026 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | S | Common Stock | 24765 | $104.24 | 60,753.0000 | 63,573,048 | 28.96% | 0.04% |
| March 26, 2026 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | M | Common Stock | 5265 | $12.17 | 85,518.0000 | 63,573,048 | 6.56% | 0.01% |
| Jan. 27, 2026 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | M | Common Stock | 12000 | $12.17 | 106,523.0000 | 63,573,048 | 12.70% | 0.02% |
| Jan. 27, 2026 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | M | Common Stock | 16000 | $19.19 | 94,523.0000 | 63,573,048 | 20.38% | 0.03% |
| Jan. 27, 2026 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | M | Stock Option (right to buy) | 16000 | $0.00 | 50,800.0000 | 63,573,048 | 23.95% | 0.03% |
| Jan. 27, 2026 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | S | Common Stock | 18203 | $83.14 | 60,320.0000 | 63,573,048 | 23.18% | 0.03% |
| Jan. 27, 2026 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | S | Common Stock | 28000 | $83.13 | 78,523.0000 | 63,573,048 | 26.29% | 0.04% |
| Jan. 27, 2026 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | M | Stock Option (right to buy) | 12000 | $0.00 | 18,547.0000 | 63,573,048 | 39.28% | 0.02% |
| Jan. 20, 2026 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | S | Common Stock | 8588 | $82.48 | 78,077.0000 | 63,573,048 | 9.91% | 0.01% |
| Jan. 2, 2026 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | A | Stock Option (right to buy) | 32000 | $0.00 | 32,000.0000 | 63,573,048 | 9999.99% | 0.05% |
| Jan. 2, 2026 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | A | Common Stock | 25600 | $0.00 | 86,665.0000 | 63,573,048 | 41.92% | 0.04% |
| April 22, 2025 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | S | Common Stock | 1756 | $46.00 | 61,065.0000 | 62,963,806 | 2.80% | 0.00% |
| March 12, 2025 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | S | Common Stock | 24903 | $58.73 | 62,821.0000 | 65,077,722 | 28.39% | 0.04% |
| March 12, 2025 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | M | Common Stock | 15203 | $12.17 | 78,024.0000 | 65,077,722 | 24.20% | 0.02% |
| March 12, 2025 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | M | Common Stock | 9700 | $19.19 | 87,724.0000 | 65,077,722 | 12.43% | 0.01% |
| March 12, 2025 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | M | Stock Option (right to buy) | 15203 | $0.00 | 30,547.0000 | 65,077,722 | 33.23% | 0.02% |
| March 12, 2025 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | M | Stock Option (right to buy) | 9700 | $0.00 | 66,800.0000 | 65,077,722 | 12.68% | 0.01% |
| Jan. 16, 2025 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | S | Common Stock | 2601 | $0.00 | 62,821.0000 | 65,077,722 | 3.98% | 0.00% |
| Jan. 16, 2025 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | S | Common Stock | 1317 | $0.00 | 65,422.0000 | 65,077,722 | 1.97% | 0.00% |
| Jan. 2, 2025 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | A | Common Stock | 31779 | $0.00 | 66,739.0000 | 65,077,722 | 90.90% | 0.05% |
| Jan. 2, 2025 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | A | Stock Option (right to buy) | 38520 | $0.00 | 38,520.0000 | 65,077,722 | 9999.99% | 0.06% |
| Sept. 11, 2024 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | S | Common Stock | 12000 | $44.47 | 34,960.0000 | 61,305,289 | 25.55% | 0.02% |
| Sept. 11, 2024 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | M | Stock Option (right to buy) | 6000 | $0.00 | 76,500.0000 | 61,305,289 | 7.27% | 0.01% |
| Sept. 11, 2024 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | M | Stock Option (right to buy) | 6000 | $0.00 | 45,750.0000 | 61,305,289 | 11.59% | 0.01% |
| Sept. 11, 2024 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | M | Common Stock | 6000 | $12.17 | 46,960.0000 | 61,305,289 | 14.65% | 0.01% |
| Sept. 11, 2024 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | M | Common Stock | 6000 | $19.19 | 40,960.0000 | 61,305,289 | 17.16% | 0.01% |
| Sept. 11, 2024 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | S | Common Stock | 2203 | $44.59 | 34,960.0000 | 61,305,289 | 5.93% | 0.00% |
| April 18, 2024 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | S | Common Stock | 1234 | $25.11 | 37,163.0000 | 63,595,328 | 3.21% | 0.00% |
| Feb. 29, 2024 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | S | Common Stock | 7850 | $30.61 | 42,734.0000 | 56,763,559 | 15.52% | 0.01% |
| March 1, 2024 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | S | Common Stock | 12000 | $32.22 | 40,645.0000 | 56,763,559 | 22.79% | 0.02% |
| March 1, 2024 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | M | Common Stock | 12000 | $12.17 | 52,645.0000 | 56,763,559 | 29.52% | 0.02% |
| Feb. 29, 2024 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | S | Common Stock | 2089 | $31.00 | 40,645.0000 | 56,763,559 | 4.89% | 0.00% |
| March 1, 2024 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | M | Stock Option (right to buy) | 12000 | $0.00 | 51,750.0000 | 56,763,559 | 18.82% | 0.02% |
| March 1, 2024 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | S | Common Stock | 2248 | $32.33 | 38,397.0000 | 56,763,559 | 5.53% | 0.00% |
| Jan. 16, 2024 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | F | Common Stock | 1452 | $24.63 | 50,584.0000 | 56,763,559 | 2.79% | 0.00% |
| Jan. 2, 2024 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | A | Stock Option (right to buy) | 78000 | $0.00 | 78,000.0000 | 56,763,559 | 9999.99% | 0.14% |
| Jan. 2, 2024 | Protagonist Therapeutics, Inc | $PTGX | Ali Asif | Chief Financial Officer | A | Common Stock | 21000 | $0.00 | 52,036.0000 | 56,763,559 | 67.66% | 0.04% |